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Novel Zinc Chelators Which Inhibit the Binding of
HIV-EPl, a Zinc Finger Protein, to NF-KB
Recognition Sequence
Masami Otsuka, Mikako Fujita, and Yukio Sugiura
In order to manipulate the function of zinc finger proteins, several zinc-binding molecules comprising
dimethylaminopyridine and histidine units have been prepared. NMR study showed that trityl and
carboxyl groups contributed to increase zinc-binding capability of the chelators. These molecules
exhibited remarkable inhibitory effect on the DNA binding of the human immunodeficiency virus type 1
enhancer binding protein HIV-EPl which contains two C2H2 type zinc fingers. DNA-binding capability of
HIV-EPl was recovered by adding extra zinc, confirming the inhibition to be caused by the removal of
zinc from HIV-EPl. This approach could be a novel strategy for the control and elucidation of
biochemical processes.
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Zinc finger proteins constitute a major group of
transcription factor and play important roles in the
gene expression. Our interest has been focused on a
C2H2 type zinc finger protein HlV-EP1 which binds
to DNA KB site (5'-GGGACTTTCC-3') present in the
long terminal repeat of HlV provirus to activates the
HlV-1 gene expression. It was thought that the func-
tion of this zinc protein could be modulated by eject-
ing the zinc and inhibition of HlV-EP1 would lead to
the interference of the replication of AIDS virus. The
objective of this study is to construct an efficient zinc-
coordinating system which can abstract zinc from
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HlV-EP1 to inhibit DNA binding.
Previously we reported a metal-chelating system
comprising a dimethylaminopyridine and histidine
methyl ester 1 (1). We considered that the structure
of the compound 1 could be modified so as to be an
efficient zinc trapper. First we tried to introduce a
trityl group into the imidazole in order to alter the
chelating characteristics of the imidazolyl group. We
also att~mpted to change the methyl ester groups of
compound 1 into carboxyls. Thus, we prepared trityl
and/or carboxyl derivatives 2-4 starting with 1 (2, 3).
Treatment of metal-free 1, 2, 3, and 4 with
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Scope of research
The major goal of our laboratory is to elucidate the molecular basis of the activity of various bioactive sub-
stances by biochemical, physicochemical, and synthetic approaches. These include studies on the mechanism
of sequence-specific DNA cleavage by antitumor or carcinogenic molecules, probing the DNA fine structure by
various chemicals, studies on the DNA recognition of zinc-finger proteins, construction of artificial restriction
enzyme, and model study on the cooperative mechanism of DNA binding by dimeric peptides. Also studied
are the design and synthesis of functional molecules that effectively regulate the intracellular signal transduc-
tion or that applicable to fluorescence detection ofDNA.
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equimolar ZnS04 in MeOH afforded the correspond-
ing 1:1 zinc complexes. Zinc-chelated 1, 2, 3, and 4
thus formed were distinguished from the metal-free
1, 2, 3, and 4 by IH or lSC NMR spectroscopy. The
zinc-binding affinity of the synthetic ligands 2, 3, and
4 was compared with that of ligand 1 by competitive
zinc binding expeiments using IH NMR. The affinity
of the ligand 1 for zinc was decreased by introducing
trityl group. However, zinc binding power was great-
ly improved by changing the methyl ester to the car-
boxyl, and RS-isomer 4 showed the highest__affinity
for zinc.
Compound I{J R2 Stereochemistry ("')
1 CH 3 H SS
2 CH Trl SS3
3 H Trl SS
4 H Trl RS
The synthetic chelators 1-4 were found to exhibit
remarkable inhibitory effect on the DNA binding of
HIV-EP1, even more potent than that of EDTA, as
demonstrated by electrophoretic mobility shift assay.
The most potent was compound 1 which inhibited the
DNA binding almost completely at 0.4 mM concentra-
tion. The most strong zinc chelator 4 showed some-
what weaker inhibition. Discrepancy between the
DNA-binding inhibitory effect and the zinc-binding
power of ligands may be due to their relatively low
solubility in aqueous media or possibly due to the dif-
ference in the dissociation of the carboxyl group of the
ligand depending on the solvent constitution
(CDsOD-D20 (4:1) for the NMR measurement and
H20-CHsOH (96:4) for the DNA-binding experi-
ments). All these ligands were shown to be stronger
inhibitors of DNA binding compared with EDTA
although EDTA showed stronger affinity for zinc,
suggesting the superiority of the nitrogen-containing
heterocyclic structure in terms of amino acid interac-
tion, hydrophobic interaction, or possibly electronic
effect favourable for the formation of presumed inter-
mediary ternary complex with HIV-EP1-Zn. When
zinc was introduced during or after the DNA-binding
inhibition reaction with compound 1 (0.7mM), total
recovery of HIV-EP1-DNA complex was observed.
Ethidium displacement and footprinting experiments
indicated that 1 has virtually no interaction with
DNA. These indicated that the inhibition was indeed
caused by the removal of zinc from the zinc finger
moiety of HIV-EP1 and ruled out a competition
between ligand 1 and HIV-EP1 for binding to DNA.
Thus, we developed novel zinc-binding heterocy-
cles and succeeded in the inhibition of DNA binding
of a zinc finger protein HIV-EPl. Since this approach
can basically be applicable to any zinc proteins and
the further structural modification of the pyridine-
histidine system could be easily attained, the present
study may provide a basis for the control and elucida-
tion of various biochemical processes.
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